Register Login

ATHIRA PHARMA, INC. (LONA)

SymbolLONA
NameATHIRA PHARMA, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address18706 NORTH CREEK PARKWAY,SUITE 104, BOTHELL, Washington, 98011, United States
Telephone+1 425 620-8501
Fax—
Email—
Websitehttps://www.athira.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001620463
Description

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimers disease and Parkinsons disease.

Additional info from NASDAQ:
LeonaBio, headquartered in the Seattle, Washington area, is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), with the goal of improving patients lives. Our lead drug candidates, lasofoxifene and ATH-1105, are novel, small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. With a strong commitment to scientific excellence and patient-centered innovation, we are dedicated to developing meaningful new therapies for those who need them most.

Additional info from NASDAQ:
Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimers disease and Parkinsons disease.

2026-05-15 21:03

New Form SCHEDULE 13G - LeonaBio, Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001104659-26-062870 <b>Size:</b> 16 KB

Read more
2026-05-11 17:57

New Form ARS - LeonaBio, Inc. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001193125-26-217029 <b>Size:</b> 5 MB

Read more
2026-05-08 00:27

Holles Natalie C. 🟢 acquired 56.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $9.63 Transaction Date: May 05, 2026 | Filing ID: 000007

Read more
2026-05-08 00:26

Silverman Peter B. 🟢 acquired 56.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $9.63 Transaction Date: May 05, 2026 | Filing ID: 000003

Read more
2026-05-08 00:24

Callori Fred 🟢 acquired 56.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $9.63 Transaction Date: May 05, 2026 | Filing ID: 000004

Read more
2026-05-07 21:24

New Form 3 - LeonaBio, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001790314-26-000002 <b>Size:</b> 12 KB

Read more
2026-05-07 21:23

New Form 3 - LeonaBio, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001580111-26-000006 <b>Size:</b> 12 KB

Read more
2026-05-07 21:23

New Form 3 - LeonaBio, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001843393-26-000003 <b>Size:</b> 12 KB

Read more
2026-05-07 20:05

(10% Negative) ATHIRA PHARMA, INC. (LONA) Announces Delay in Lasofoxifene Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Read more
2026-05-07 17:20

New Form SCHEDULE 13D/A - LeonaBio, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212047 <b>Size:</b> 12 KB

Read more